Teladoc Health Sees Unusually High Options Volume (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC) saw unusually large options trading on Wednesday. Investors bought 20,867 call options on the company. This is an increase of 50% compared to the average volume of 13,918 call options.

Insider Buying and Selling

In related news, insider Carlos Nueno sold 2,389 shares of the firm’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total value of $28,500.77. Following the transaction, the insider now directly owns 2,890 shares of the company’s stock, valued at approximately $34,477.70. This trade represents a 45.25 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.95% of the stock is owned by insiders.

Hedge Funds Weigh In On Teladoc Health

A number of large investors have recently bought and sold shares of the business. Blue Trust Inc. raised its stake in Teladoc Health by 84.5% in the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock worth $40,000 after buying an additional 1,854 shares in the last quarter. Versant Capital Management Inc raised its stake in Teladoc Health by 313.8% in the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after buying an additional 2,441 shares in the last quarter. Westside Investment Management Inc. raised its stake in Teladoc Health by 43.8% in the fourth quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider’s stock worth $84,000 after buying an additional 2,800 shares in the last quarter. Private Advisor Group LLC raised its stake in Teladoc Health by 26.9% in the third quarter. Private Advisor Group LLC now owns 13,990 shares of the health services provider’s stock worth $128,000 after buying an additional 2,962 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. raised its stake in Teladoc Health by 209.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 5,015 shares of the health services provider’s stock worth $49,000 after buying an additional 3,396 shares in the last quarter. Institutional investors own 76.82% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Barclays raised their target price on Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. Royal Bank of Canada raised their price target on Teladoc Health from $9.00 to $10.00 and gave the company an “outperform” rating in a report on Wednesday, October 9th. Deutsche Bank Aktiengesellschaft raised their price target on Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a report on Friday, November 1st. Evercore ISI lifted their target price on Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Finally, The Goldman Sachs Group began coverage on Teladoc Health in a report on Friday, November 15th. They issued a “buy” rating and a $14.00 target price on the stock. Fourteen analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, Teladoc Health has a consensus rating of “Hold” and a consensus price target of $12.24.

Teladoc Health Stock Performance

Teladoc Health stock opened at $9.88 on Thursday. The company has a 50 day moving average price of $9.97 and a 200-day moving average price of $9.03. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. Teladoc Health has a fifty-two week low of $6.76 and a fifty-two week high of $21.74. The company has a market capitalization of $1.70 billion, a PE ratio of -1.71 and a beta of 1.01.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The firm had revenue of $640.51 million during the quarter, compared to the consensus estimate of $630.50 million. As a group, equities analysts forecast that Teladoc Health will post -1.16 earnings per share for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.